HundredX  data shows strong growth is expected for the cruise industry compared to other travel sectors.

This article was originally published in the online publication: CruiseHive and is based off the original Insights article that HundredX published

The CruiseHive article can be found by clicking here.   It was published on July 25, 2022 . Written by Robert McGillivray


Over the past months, news reports that the cruise industry would be in for some tough times have been plentiful. Those thoughts are not exactly unexpected with the looming recession and inflation spiking worldwide. 


However, in recent research by HundredX, an innovative real-time market share strategy platform, the cruise industry could rebound much more robust than previously expected. The industry could soon show more substantial rebound numbers than other travel segments, setting the stage for cruising to surpass pre-pandemic numbers. 


Inflation and Recession Could Bypass Cruise Industry


With stock prices at an all-time low, the cruise industry is certainly not the first place investors would be looking at to get a decent return on investment. Although Carnival had a spike to over $11 a share last week, the world’s largest cruise operator is back at $9 today.


Similar examples can be seen in Royal Caribbean and Norwegian Cruise Line, although these two are doing better as debts are not placing too much of a burden on their finances. Even then, confidence in cruise companies seems to be bearish, with the belief prices will fall even further as inflation and recession start taking hold in households worldwide. 


However, that sentiment is outdated according to the market share strategy platform HundredX. During research released on data collected from over 35,000 cruisers, the company shows that the cruise industry is leading a much stronger rebound than other travel segments such as airlines, hotels, and car rentals. 



As vacationers increasingly report an intention to cruise again before the end of 2022, the industry is expected to sustain its upward trajectory, which has been building significantly since March 2022.


The methodology behind the research from HundredX followed looking at the intent to book a cruise, customers saying yes, they will book a cruise this year, minus those that would not. While the numbers were at -25% during 2020, the number spiked to +20% in the first quarter of 2021. 

Those numbers bottomed out in March 2022, but the three months through June 2022 showed continuous improvement. The record levels of growth this summer shouldn’t have been surprising to investors as “the crowd” was making it clear that they planned to keep cruising.


Fears of recession and inflation might be big news in the media, but so far, there seems to be little impact on cruise companies, and that in itself is not surprising when we look at what is happening in the industry.


Post-Pandemic, More People Are Coming Back Onboard Each Day


During the early days after the global pause in operations, cruise executives could not contain their excitement. Bookings were sky high, and the industry would soon be back on top. However, that could have been more showing off to investors than reality. With billions in debt, the cruise industry needed people onboard, and nothing gets people onboard more than saying that everyone is doing it. However, with COVID-19 still a real threat, vaccine rollout in the early stages, 30-40% occupancy levels, and drastic measures onboard, not that many people booked cruises. 


Currently, the situation offers a vastly different reality. People are returning to cruising en masse as ships have proven to be a healthy and safe vacation option with vaccine mandates and pre-cruise testing.


Add to that the issues that airlines and airports seem to be having with the massive influx of travelers, and all of a sudden, taking a cruise is a great option. 

Cruise consumers also indicated their top booking drivers to HundredX, and here as well shows what many other vacation destinations cannot offer, excellent food and beverage quality, low pricing, ship cleanliness, entertainment, staff service, a focus on health and safety, and comfortable staterooms.


Yes, cruise companies struggle to control the massive amount of debt they accumulated during the Pandemic. But, with cruise companies hedging their fuel well in advance, high fuel prices have not affected pricing.  Yes, cruise stocks are still at an all-time low. But, this could very well be due to a misplaced sentiment from investors. The number shows that cruising is as popular or even more popular than ever. 

Related Cruise Industry News Articles

This article was  published in the following online publications and is based off the original Insights article that HundredX published


Cruisehive.com

CruiseBusiness.com

Cruise & Ferry


Strategy Made Smarter


HundredX works with a variety of companies and their investors to answer some of the most important strategy questions in business:

  • Where are customers "migrating"?
  • What are they saying they will use more of in the next 12 months?
  • What are the key drivers of their purchase decisions and financial outcomes?


Current clients see immediate benefits across multiple areas including strategy, finance, operations, pricing, investing, and marketing.


Our insights enable business leaders to define and identify specific drivers and decisions enabling them to grow their market share.


Please contact our team to learn more about which businesses across 75 industries are best positioned with customers and the decisions you can make to grow your brand’s market share.

Share This Article

06 May, 2024
Sure, lattes, mochaccinos, and cappuccinos are pricey, but they taste delicious. For many consumers, the great taste of coffee shop coffee made it worth the cost. But customers at Starbucks aren't so sure the tradeoff is worth it anymore. Examining more than 420,000 pieces of feedback across the Quick, Fast, Casual (QFC) industry, including over 21,000 on Starbucks, we find: Starbuck's Purchase Intent 1,2 is down 3% over the past six months, with most of that dip occurring over the past few months. By contrast, Dunkin' Donuts has remained within a tight range over the past six months, as did an average of other, smaller coffee chains. Customers increasingly see less value in Starbucks. Starbuck's Value perception 3 fell 5% over the past six months, compared to just 1% for Dunkin' Donuts. However, it also fell 5% for the average of the smaller coffee chains. Coffee drinkers feel significantly unhappier about Starbuck's quality and taste. Starbuck's Taste perception fell 4% over the past six months, while rising 1% for competitors. Likewise, its Quality perception dipped 3% over the same time period (and 8% over the year). Ultimately, Starbuck's perceived drop in taste is leading inflation-weary consumers to say they plan to spend less at the coffee chain, as the value just isn't as good.
06 May, 2024
Forbes Best Brands for Social Impact, Powered by HundredX
06 May, 2024
Ozempic once dominated the headlines, but GLP-1 competitor Mounjaro is winning over customers. GLP-1 drugs, used for treating diabetes and aiding in weight loss, are relatively new on the market yet have surged in popularity over the last year. They're becoming so popular that J.P. Morgan estimates that 30 million people in the US may be using a GLP-1 drug by 2030. This statistic presents a significant potential for early drug creator Novo Nordisk (Ozempic, Wegovy), and perhaps an even bigger one for Eli Lilly (Mounjaro, Zepbound). HundredX data indicates Eli Lilly is in a position to win over Novo Nordisk as Mounjaro's Usage Intent widens against the competition. Ozempic may have name recognition, but customers feel more positively about Mounjaro's effectiveness and lifestyle impact, even if they aren't excited about its high price. Examining 1,500 pieces of customer feedback across Mounjaro, Ozempic, and Wegovy, we find: GLP-1 users increasingly say they plan to use Mounjaro more, and Ozempic less . Mounjaro’s Usage Intent is up 19% since July, Wegovy’s is up 3%, and Ozempic has stayed within a tight range. Customers feel Mounjaro is more effective than competing drugs, but it’s harder to get . Mounjaro outperforms other GLP-1 drugs in effectiveness, lifestyle impact, and side effects. However, customers dislike its cost and availably more than competitors.
Share by: